Daytrana patches recalled by Shire - MPR

Links shared publicly online about this topic.

  • 1,557
    total visits

Daytrana patches recalled by Shire - MPR

empr.com

Shire is voluntarily recalling five lots and withdrawing one lot of Daytrana (methylphenidate transdermal system) due to difficulty removing the release liner from some of the patches.

View full resource at empr.com

Tags: ADHD Medication, Concerta, Metadate CD, Metadate ER, Methylin, Ritalin, Shire

  • Share

Most Recently Shared on December 3, 2009 at 4:58 pm By:

eMPR MPR

MPR News: Daytrana patches recalled by Shire: Shire is voluntarily recalling five lots and withdrawing one lot of D... http://bit.ly/6nkaAK

2 years ago...

Noven Completes Acquisition of Daytrana Methylphenidate Transdermal System (CII) from Shire - Drugs.com MedNews

drugs.com — “First and Only Patch for ADHD Now to be Marketed and Sold by Noven Therapeutics Oct 1, 2010 - Noven Pharmaceuticals, Inc. today announced that it has completedView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on October 1, 2010 at 4:19 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Noven Completes Acquisition of Daytrana Methylphenidate Transdermal System (CII) from Shire: First and Only P... http://bit.ly/9YGHxH #drug

2 years ago...

Goodbye to the ADHD Patch: After 9 Recalls and a Federal Probe, Shire Gives Up | BNET

bnet.com — “Back in December, I suggested that Shire (SHPGY) should ditch Daytrana, its ADHD patch for kids, because the liners on the device malfunctioned so freView full resource at bnet.com

  • View Related
  • Share

Most Recently Shared on August 11, 2010 at 8:39 pm By:

Jim_Edwards Jim Edwards Health Communicator

Goodbye to the ADHD Patch: After 9 Recalls and a Federal Probe, Shire Gives Up: Back in December, I suggested that... http://bit.ly/9tPNeV

2 years ago...

Shire receives FDA approval of Daytrana for ADHD in adolescents

news-medical.net — “Shire plc, the global specialty biopharmaceutical company, announced the US Food and Drug Administration (FDA) approval of Daytrana® (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents aged 13 to 17 years. Daytrana, the first and only transdermal ADHD patch, is already an FDA-approved ADHD treatment for children 6 to 12 years. Daytrana is indicated as an integral part of a total treatment program for ADHD that may include View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on July 7, 2010 at 5:40 am By:

NewsMedical News-Medical.Net Health News

Shire receives FDA approval of Daytrana for ADHD in adolescents: Shire plc, the global specialty biopharmaceutical... http://bit.ly/atTr4s

2 years ago...

Shire's Daytrana Patch Recall Is 8th So Far: Time to Pull the Plug? | BNET Pharma Blog | BNET

industry.bnet.com — “Shire (SHPGY) has voluntarily recalled the Daytrana ADHD patch citing problems with patients removing the liner on the back. It is not a safety issue,View full resource at industry.bnet.com

  • View Related
  • Share

Most Recently Shared on December 7, 2009 at 4:49 pm By:

Jim_Edwards Jim Edwards Health Communicator

Shire's Daytrana Patch Recall Is 8th So Far: Time to Pull the Plug?: Shire (SHPGY) has voluntarily recalled the Day... http://bit.ly/5d1A9H

2 years ago...

Subscription Center - News Archive

pharmalive.com — “Subscription Center - News ArchiveView full resource at pharmalive.com

  • View Related
  • Share

Most Recently Shared on December 3, 2009 at 6:40 pm By:

pharmalive PharmaLive Pharma and Health News

Shire Announces Second Limited Recall of ADHD Patch Daytrana-http://tinyurl.com/yz7jqky

2 years ago...

Advertisement